期刊文献+

骨疏颗粒对去卵巢骨质疏松大鼠骨密度及血清细胞因子的影响 被引量:9

Effect of Gushu powder on bone mineral density and serum cytokines in rats with osteoporosis following ovriectomy
下载PDF
导出
摘要 目的观察骨疏颗粒对去卵巢骨质疏松大鼠骨密度及血清细胞因子的影响,探讨骨疏颗粒防治骨质疏松症的可能作用机制。方法将3月龄SD雌性大鼠40只,按随机数字表法分为空白组、模型组、戊酸雌二醇组及骨疏颗粒组。空白组只行假手术,其余3组用去大鼠双侧卵巢复制绝经后骨质疏松症的模型。术后3天分别给戊酸雌二醇及骨疏颗粒灌胃,12周后检测血清白细胞介素(interleukin,IL)1β、IL-6、肿瘤坏死因子(tumor necrosis factor,TNF)-α及左股骨骨密度。结果(1)与空白组比较,模型组骨密度显著下降,血清IL-1β及IL-6显著增加(P<0.01),TNF-α增加(P<0.05);(2)与模型组比较,戊酸雌二醇组骨密度显著增加(P<0.01),血清IL-1β显著降低(P<0.01),IL-6及TNF-α均降低(P<0.05);骨疏颗粒组骨密度增加(P<0.05),血清IL-1β、IL-6及TNF-α均降低(P<0.05)。结论骨疏颗粒对去卵巢骨质疏松大鼠有治疗作用,其作用机制可能是通过降低血清中IL-1β、IL-6及TNF-α细胞因子水平,从而抑制骨吸收。 Objective To observe Gushu powder treating rats with ovriectomy osteoporosis, and explore the mechanism of Gushu powder protecting and treating osteoporosis. Methods According to random number table, forty SD female rats of three months were randomly divided into four groups: sham group, model group, estradiol valerate group, and Gushu powder group. The sham group only got sham-operation and the other three groups were ovriectomized respectively. Three days later after ovriectomy, the rats were given estradiol valerate ( 0. 5 mg/kg ) and Gushu powder ( 10 mL/kg ) by intragastric administration for twelve weeks. Bone minereal density(BMD) was detected with dual-energy X-ray ab-sorptiometry. Serum interleukin-1 beta(IL-1β),interleukin-6(IL-6) and tumor necrosis factor alpha(TNF-α) were detected. Results ( 1 ) Compared with the sham group, the BMD significantly decreased (P〈0.01),IL-1β and IL-6 significantly increased(P〈0. 01), and TNF-α increased in model group (P〈0.05). (2)Compared with model group,BMD in Bujiale group dramatically increased(P〈0.01), IL-1β significantly decreased(P〈0. 01),IL-6 and TNF-α decreased(P〈0. 05). While in Gushu powder group, BMD in Bujiale group increased(P〈0. 05);IL-1β, IL-6 and TNF-α decreased(P〈0.05).&amp;nbsp;Conclusions Gushu powder may prevent and treat osteoporosis through reducing sereum IL-1β, IL-6 and TNF-α which can depress bone absorption.
出处 《环球中医药》 CAS 2015年第9期1081-1084,共4页 Global Traditional Chinese Medicine
基金 云南省教育厅科学研究基金(2011Y410 2012C034) 云南白药 云南中医学院中医药教育创新基金(YB2011J06) 云南中医学院科研基金(XK201309) 云南省中医院院级科研(2011YJ034)
关键词 骨疏颗粒 骨质疏松 骨密度 白介素-1Β 白介素-6 肿瘤坏死因子-α Gushu powder Osteoporosis Bone mineral density Interleukin-1beta Tumor necrosis factor-alpha
  • 相关文献

参考文献16

二级参考文献59

共引文献220

同被引文献131

  • 1吴佳宝,赵军,李婧,郁金岗,吕新亮,赵真梓,姜婷,刘岩.中西医结合防治骨质疏松症研究进展[J].内蒙古中医药,2023,42(3):140-142. 被引量:4
  • 2王斌,邓高鹏,侯平.骨康胶囊治疗女性绝经后骨质疏松患者189例[J].中国老年学杂志,2014,34(12):3473-3474. 被引量:10
  • 3孙丽娟,陈静.雌激素替代治疗绝经后骨质疏松的疗效观察[J].中国临床康复,2004,8(18):3450-3450. 被引量:5
  • 4关俭,唐洁凤,郭光荣,郭荣林,黄斌.六味地黄丸对绝经后骨质疏松患者骨密度的干预作用[J].中国中医药信息杂志,2006,13(12):70-71. 被引量:13
  • 5Jones DR.A potential osteoporosis target in the FAS ligand/FAS pathway of osteoblast to osteoclast signaling. Ann "l'ransl Med.2015;3(14): 189.
  • 6Okazaki R.Pharmacological treatment of other types of secondary osteoporosis.Nihon Rinsho.2015;73(10): 1740-1745.
  • 7Ostrowska Z,Ziora K,OwiQcimska J,et al.Selected pro-inflammatory cytokines, bone metabolism, osteoprotegerin, and receptor activator of nuclear factor-kB ligand in girls with anorexia nervosa. Endokrynol Po1.2015;66(4):313-21.
  • 8AI-Daghri NM,Yakout S,AI-Shehri E,et al.lnflammatory and bone turnover markers in relation to PTH and vitamin D status among saudi postmenopausal women with and without osteoporosis.lnt J Clin Exp Med.2014; 7(10):3528-3535.
  • 9He LH,Xiao E,Duan DH,et aI.Osteoclast Deficiency Contributes to Temporomandibular Joint Ankylosed Bone Mass Formation.J Dent Res.2015;94(10): 1392-1400.
  • 10Ardawi MM,Badawoud MH,Hassan SM,et aI.Lycopene treatment against loss of bone mass, microarchitecture and strength in relation to regulatory mechanisms in a postmenopausal osteoporosis model.Bone.2015;83: 127-140.

引证文献9

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部